TuisCRL • NYSE
add
Charles River Lbrtrs ntrntl Inc
Vorige sluiting
$177,85
Dagwisseling
$160,01 - $180,19
Jaarwisseling
$91,86 - $230,02
Markkapitalisasie
8,25Â mjd USD
Gemiddelde volume
1,02Â m
P/V-verhouding
-
Dividend-opbrengs
-
PrimĂŞre beurs
NYSE
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 1,03Â mjd | 0,59% |
Bedryfskoste | 211,51Â m | 8,67% |
Netto inkomste | 52,33Â m | -44,38% |
Netto winsgrens | 5,07 | -44,71% |
Wins per aandeel | 3,12 | 11,43% |
EBITDA | 327,04Â m | 26,18% |
Effektiewe belastingkoers | 26,22% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 182,82Â m | 2,01% |
Totale bates | 7,56Â mjd | -4,88% |
Totale aanspreeklikheid | 4,16Â mjd | -0,34% |
Totale ekwiteit | 3,40 mjd | — |
Uitstaande aandele | 49,21 m | — |
Prys om te bespreek | 2,61 | — |
Opbrengs op bates | 5,68% | — |
Opbrengs op kapitaal | 6,93% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 52,33Â m | -44,38% |
Kontant van bedrywe | 204,60Â m | 5,72% |
Kontant van beleggings | -37,34Â m | 39,65% |
Kontant van finansiering | -226,92Â m | 20,62% |
Netto kontantverandering | -46,99Â m | 70,17% |
Beskikbare kontantvloei | 228,38Â m | 54,82% |
Meer oor
Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices. Its operations span at least 20 countries, offering research models, safety assessment, and manufacturing support services to pharmaceutical, biotechnology, and government clients.
Charles River Laboratories is considered one of the largest CROs globally, known for its role in toxicology studies, animal research models, and microbial testing services used in regulatory submissions to health authorities such as the U.S. Food and Drug Administration. The company has also been the subject of public scrutiny and regulatory attention over its use of laboratory animals, including dogs, primates, and horseshoe crabs.
As of 2024, the company employs over 20,000 people worldwide and is publicly traded on the New York Stock Exchange under the ticker symbol CRL. Wikipedia
Gestig
1947
Webwerf
Werknemers
19Â 400